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In female pelvic pain evaluation and management, gynecologists still lack precise 14 
methods to determine when the uterus is the primary problem. Patients with chronic 15 
pain often encounter futility seeking specific and explicit diagnostic labels for their 16 
distress. A dizzying array of supporting sources competes to advise them: the lay press, 17 
internet support sites, and all too often, cursory, balkanized initial evaluation by 18 
clinicians (ambulatory and in urgent care settings). In fact, the evidence base proving 19 
that leiomyoma-, adenomyosis-, or even endometriosis-associated uterine pain are 20 
always stable constructs over time remains distressingly small.  This is particularly the 21 
case in patients with daily chronic symptoms.  Hysterectomy in many cases provides a 22 
durable solution where leiomyoma, an island of adenomyosis, or a block of dense scar 23 
from a uterosacral endometriotic nodule is found in the final pathology report. Yet, there 24 
are frequent counterexamples where pain symptoms persist postoperatively despite 25 
removal of pelvic pathology.  What tools might help determine when uterine surgery will 26 
be helpful?  Validated clinical assessments for the presence of uterine pain on 27 
examination, and physiological studies of abnormal patterns of uterine blood flow or 28 
myometrial contractility could prove helpful, but would need systematic study in larger 29 
cohorts of women.  To jump start this process, we wish to make a modest proposal – 30 
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as chronic uterine pain within the International Association for the Study of Pain’s 1 
(IASP) Taxonomy of Pain umbrella term--chronic pelvic pain syndromes (CPP).1 This 2 
philosophical reappraisal could accelerate adoption of an overarching, symptom- and 3 
exam-based approach to CPP disorders. Deliberate attention to consistent subtypes of 4 
CPP based on symptoms and location of pain, complementing histologic and imaging 5 
defined features, could refine how to select appropriate hormonal, neurological, and 6 
procedural treatments.2 Given that only about two dozen small treatment trials for 7 
nonspecific CPP have been published and generally only have employed counseling, 8 
manual therapy, or psychoactive medications, the opportunity for progress is large.3
 To some, adding a chronic uterine pain term may seem unproductive, leading to 10 
further splitting of a field already encumbered by excessive terminology. Yet a periodic 11 
reappraisal of terms, particularly when hypothesis driven, can be a natural, healthy 12 
development in the study of contested disease states.  There is substantial justification 13 
to move to an organ-centric view of chronic pelvic pain from the successful efforts to 14 
investigate two closely related disorders, painful bladder syndrome/interstitial cystitis 15 
(PBS) and irritable bowel syndrome (IBS). Unlike endometriosis-associated pelvic pain, 16 
neither is based on histological classification, but instead are defined by organ and 17 
symptom-based diagnostic criteria.  Both have benefited from extensive NIH funded 18 
multidisciplinary research portfolios, which have validated that both conditions represent 19 
mind-body integration disorders, rather than being characterized solely by peripheral 20 
inflammation.  While PBS and IBS are defined by absence of visible clinical disease 21 
within the “organ of pain”, investigators increasingly accept that the same central 22 
features can be present in patients with significant peripherally identifiable pathology.   23 
As a notable example, inflammatory bowel disease (IBD) is a well-recognized disorder 24 
with histological criteria for diagnosis, but it has been studied using parallel techniques 25 
for studying IBS, due to overlapping symptoms of abdominal pain.  Intriguingly Keefer 26 
and colleagues have applied mind-body therapies to IBD patients and found that 27 
hypnosis in a double-blinded RCT significantly reduced IBD symptom flares over a year.  28 
They postulated this might be through immune-mediated pathways, suggesting that in 29 
turn endometriosis and other chronic uterine pain states, which also may arise from 30 
immune surveillance dysfunction, deserve similar investigation.
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 Similarly, accumulating evidence supports the thesis that CPP patients, 1 
regardless of observable pelvic pathology, likely share common mechanisms of pain. 2 
Evidence of dysfunction in the peripheral and central nervous system can be identified 3 
broadly in women with CPP.  The presence of nociceptive Aδ and C fiber nerves 4 
infiltrating endometriosis lesions was reported in both symptomatic women and rat 5 
models more than 10 years ago.5,6 More recently, the eutopic endometrium of women 6 
afflicted with endometriosis and other causes of CPP, including adenomyosis and 7 
leiomyoma, was found to be imbued with a significantly denser nerve network than pain-8 
free controls, suggesting that this phenomenon underlies many chronic pain states, not 9 
just those with biopsy-proven endometriosis.7 Studies investigating markers of central 10 
pain amplification in CPP also show independence from the presence of peripheral 11 
pathology. For example, we have observed that women with CPP, regardless of 12 
endometriosis status and severity, exhibit hyperalgesia to experimental pain testing at a 13 
non-pelvic site.8 Neuroimaging studies, which may reveal the neurobiological 14 
mechanisms of widespread hyperalgesia and altered pain sensitivity, have shown 15 
alterations in regional gray matter volume, chemistry and regional connectivity in CPP 16 
states.9  Similar to fibromyalgia, decreased gray matter volume (GMV) in key pain 17 
regulatory regions such as the thalamus, cingulate gyrus, putamen, and insula, as well 18 
as increased concentrations of excitatory neurotransmitters in the insula, have been 19 
shown in women with CPP, again in those with and without endometriosis.10 20 
Furthermore, women with endometriosis without CPP did not exhibit hyperalgesia or 21 
changes in regional GMV but did demonstrate increased GMV in the periaqueductal 22 
gray (PAG), a key structure in the endogenous pain inhibitory system. This data 23 
suggests that patients with endometriosis without CPP experience little if any pelvic pain 24 
in part due to adaptive, antinociceptive activity of the CNS. Widespread hyperalgesia 25 
and parallel changes in central nervous system function is even identified in women with 26 
dysmenorrhea, prior to transitioning to chronic pain.11  Adding a uterine-based 27 
classification for pain states would promote treatment and longitudinal studies drawn 28 
from this body of evidence, recognizing that clinical pain experience is likely determined 29 
by a complex interaction between equally important peripheral triggers (e.g., 30 
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changes in the CNS pain regulatory system (e.g. altered GMV, neurotransmitter levels, 1 
and connectivity).  2 
An obvious concern may be raised with our proposal. Will use of the term chronic 3 
uterine pain discourage appropriate investigation of peripheral, intra-abdominal 4 
pathology such as endometriosis or adenomyosis? We would discourage this 5 
reductionism. Consistent description of the primary exam and symptom-based features 6 
of CPP patients in treatment trials need not interfere with current diagnostic and 7 
management strategies, while greatly encouraging prospective multidimensional 8 
analyses. We recommend continued treatment of obvious cases of extensive 9 
endometriosis or symptomatic bulky leiomyoma, but at the same time, we can conduct 10 
trials of myomectomy for smaller leiomyoma if a standardized exam repeatedly 11 
identifies uterine pain. Anecdotally, we observe that myomectomy of small < 2 cm 12 
leiomyoma does seem to help selected patients, particularly if extensive trials of 13 
hormonal suppression, physical therapy, and oral neuromodulators have already proven 14 
unsuccessful. However, at present no treatment trials exist to support this hypothesis.  15 
We could also begin aggressive tracking of putative cases of post-pelvic inflammatory 16 
disease (PID) chronic uterine pain, which based on current clinical diagnostic criteria, 17 
can only be labeled as infectious in origin. Notably, in a multi-site American randomized 18 
clinical trial of PID antibiotic treatment, utilizing clinically defined, pelvic exam-based 19 
diagnostic criteria, one-third of women still had CPP three months post-treatment. Given 20 
that no histological or culture-based confirmation was performed, at least a portion of 21 
these women may have actually been presenting with the occult onset of chronic uterine 22 
pain.12 Likewise, IASP already defines in its Taxonomy of Pain an ovarian pain 23 
syndrome that seems largely ignored as a diagnostic entity in the published literature 24 
that would benefit from similar inquiry. A major unmet need is also to conduct a 25 
longitudinal study of the natural history of uterine pain, while also comparing trajectories 26 
between symptoms and anatomic subtypes.  Published studies of the underlying pain 27 
mechanisms of women with symptomatic stage I-II endometriosis, who frequently report 28 
dysmenorrhea, are quite small because of the need to perform surgical biopsy.  Freed 29 
from an endometriosis-dominant framework, studies of chronic uterine pain could recruit 30 
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subanalyses of  “endometriosis confirmed” subgroups for those willing to undergo 1 
surgery. 2 
In summary, we propose that validation of an umbrella construct, “chronic uterine 3 
pain”, be subjected to stakeholder and researcher assessment, paralleling the 4 
processes used to define PBS and IBS. A working definition could start with women with 5 
pain perceived to originate from the midline deep anatomical pelvis, not clearly 6 
attributable to other nonuterine structures or obvious acute pelvic pain diagnoses.  7 
Patients should report at least 3 months of pain with pain occurring for more than 10 8 
days per month. Focal examination of the uterus should reproduce pain consistent with 9 
the clinical symptoms during periods of pain, on 2 separate occasions at least 1 month 10 
apart with standardized transvaginal clinical palpation of the uterus. Pathologic and 11 
clinical subtypes should be captured based on imaging and prior surgical findings – 12 
leiomyoma, adenomyosis, endometriosis, and post-procedural associated pain 13 
(endometrial ablation, cesarean section, hysteroscopic tubal occlusion), with the ability 14 
to include a “not formally-assessed category” within each potential subtype. 15 
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